Advanced Medicine

Nick Crabb explains the UK’s health technology assessment agency's (NICE's) approach to cell and gene therapies.

Conversations around drug pricing look set to continue for years, but the industry is also experiencing fantastic breakthroughs in science.

The supply of cell and gene therapies is a delicate operation – and easily broken, just like daisy chains.

What lies ahead for Gene and Eva in 2019? Cell and gene therapies!

Cell and gene therapies can live up to their potential – the field just needs to transform medicine as we know it.

A report highlights the acceleration of cell and gene therapy approvals worldwide.

Converting glial cells to neurons, more effective CAR-Ts, and groundbreaking IDAs… What’s new in the advanced medicine field?

With all the hope and promise emanating from the cell and gene therapy field today, it’s easy to forget that we’ve had false dawns in the past.

We should be thrilled with the success of the approved CD-19 CAR-T therapies. But the field is still young, and we are only scratching the surface.

Here we discuss the problems of handling living, breathing cells in transit...